Digitek Manufacturer Actavis Totowa Issues Recall For All Other Drugs

By Aaron Poehler

Published on August 28, 2008

The makers of the recalled Digitek brand of digoxin have announced a voluntary recall on all pharmaceutical products manufactured at their Little Falls, NJ facility due to the results of their 2008 FDA inspection.

According to a press release issued by Morristown, New Jersey-based Actavis Totowa, the pharmacy/retail level recall which includes wholesalers and hospitals was issued due to operations at their Little Falls manufacturing facility failing to meet either the FDA's or Actavis Totowa's own standards for good manufacturing practices. Because the recall does not extend to the consumer level, patients who are currently taking any of the recalled drugs are encouraged to consult with their doctors about their options before discontinuing use of their medications.

The recall covers about 65 different prescription drugs manufactured by the company, including various painkillers, antidepressant drugs, diet medications, and drugs for treatment of blood pressure and hypertension. The company emphasized in its released statement that the recall was not issued as the result of any product complaints or health hazards related to any of the recalled products.

A major recall of Actavis Totowa's Digitek brand of digoxin tablets was issued in April of this year after it was discovered that tablets were being produced at twice the dosage listed on product packaging.

 

Comment on this article →